BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28224212)

  • 1. Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress.
    Mimura K; Kua LF; Shimasaki N; Shiraishi K; Nakajima S; Siang LK; Shabbir A; So J; Yong WP; Kono K
    Cancer Immunol Immunother; 2017 May; 66(5):605-613. PubMed ID: 28224212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of highly cytotoxic human natural killer cells for cancer cell therapy.
    Fujisaki H; Kakuda H; Shimasaki N; Imai C; Ma J; Lockey T; Eldridge P; Leung WH; Campana D
    Cancer Res; 2009 May; 69(9):4010-7. PubMed ID: 19383914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of Highly Cytotoxic Natural Killer Cells for Esophageal Squamous Cell Carcinoma Treatment.
    Lim KS; Mimura K; Kua LF; Shiraishi K; Kono K
    J Immunother; 2018; 41(6):261-273. PubMed ID: 29683892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer.
    Mimura K; Kamiya T; Shiraishi K; Kua LF; Shabbir A; So J; Yong WP; Suzuki Y; Yoshimoto Y; Nakano T; Fujii H; Campana D; Kono K
    Int J Cancer; 2014 Sep; 135(6):1390-8. PubMed ID: 24615495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells.
    Yang Y; Neo SY; Chen Z; Cui W; Chen Y; Guo M; Wang Y; Xu H; Kurzay A; Alici E; Holmgren L; Haglund F; Wang K; Lundqvist A
    J Clin Invest; 2020 Oct; 130(10):5508-5522. PubMed ID: 32673292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ; Kuo ML
    Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
    Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo expansion of natural killer cells using cryopreserved irradiated feeder cells.
    Baek HJ; Kim JS; Yoon M; Lee JJ; Shin MG; Ryang DW; Kook H; Kim SK; Cho D
    Anticancer Res; 2013 May; 33(5):2011-9. PubMed ID: 23645750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-West Nile virus activity of in vitro expanded human primary natural killer cells.
    Zhang M; Daniel S; Huang Y; Chancey C; Huang Q; Lei YF; Grinev A; Mostowski H; Rios M; Dayton A
    BMC Immunol; 2010 Jan; 11():3. PubMed ID: 20089143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cells.
    Siernicka M; Winiarska M; Bajor M; Firczuk M; Muchowicz A; Bobrowicz M; Fauriat C; Golab J; Olive D; Zagozdzon R
    Immunology; 2015 Sep; 146(1):173-83. PubMed ID: 26094816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway.
    Furuke K; Shiraishi M; Mostowski HS; Bloom ET
    J Immunol; 1999 Feb; 162(4):1988-93. PubMed ID: 9973469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications.
    Lapteva N; Durett AG; Sun J; Rollins LA; Huye LL; Fang J; Dandekar V; Mei Z; Jackson K; Vera J; Ando J; Ngo MC; Coustan-Smith E; Campana D; Szmania S; Garg T; Moreno-Bost A; Vanrhee F; Gee AP; Rooney CM
    Cytotherapy; 2012 Oct; 14(9):1131-43. PubMed ID: 22900959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21.
    Kweon S; Phan MT; Chun S; Yu H; Kim J; Kim S; Lee J; Ali AK; Lee SH; Kim SK; Doh J; Cho D
    Front Immunol; 2019; 10():879. PubMed ID: 31105701
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells.
    Stangl S; Gross C; Pockley AG; Asea AA; Multhoff G
    Cell Stress Chaperones; 2008; 13(2):221-30. PubMed ID: 18759005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.
    Ayello J; Hochberg J; Flower A; Chu Y; Baxi LV; Quish W; van de Ven C; Cairo MS
    Exp Hematol; 2017 Feb; 46():38-47. PubMed ID: 27765614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self.
    Michen S; Frosch J; Füssel M; Schackert G; Momburg F; Temme A
    Cytotherapy; 2020 Jul; 22(7):354-368. PubMed ID: 32451262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15.
    Imamura M; Shook D; Kamiya T; Shimasaki N; Chai SM; Coustan-Smith E; Imai C; Campana D
    Blood; 2014 Aug; 124(7):1081-8. PubMed ID: 25006133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
    Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C
    BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?
    Fernández L; Leivas A; Valentín J; Escudero A; Corral D; de Paz R; Vela M; Bueno D; Rodríguez R; Torres JM; Díaz-Almirón M; López-Collazo E; Martinez-Lopez J; Pérez-Martínez A
    Transfusion; 2018 Jun; 58(6):1340-1347. PubMed ID: 29542132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Uncoupling of Canonical Phenotypic Markers and Functional Potency of
    Lieberman NAP; DeGolier K; Haberthur K; Chinn H; Moyes KW; Bouchlaka MN; Walker KL; Capitini CM; Crane CA
    Front Immunol; 2018; 9():150. PubMed ID: 29456538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.